Association between perinatal interventional activity and 2-year outcome of Swiss extremely preterm born infants: a population-based cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
15 03 2019
Historique:
entrez: 18 3 2019
pubmed: 18 3 2019
medline: 17 3 2020
Statut: epublish

Résumé

To investigate if centre-specific levels of perinatal interventional activity were associated with neonatal and neurodevelopmental outcome at 2 years of age in two separately analysed cohorts of infants: cohort A born at 22-25 and cohort B born at 26-27 gestational weeks, respectively. Geographically defined, retrospective cohort study. All nine level III perinatal centres (neonatal intensive care units and affiliated obstetrical services) in Switzerland. All live-born infants in Switzerland in 2006-2013 below 28 gestational weeks, excluding infants with major congenital malformation. Outcomes at 2 years corrected for prematurity were mortality, survival with any major neonatal morbidity and with severe-to-moderate neurodevelopmental impairment (NDI). Cohort A associated birth in a centre with high perinatal activity with low mortality adjusted OR (aOR 0.22; 95% CI 0.16 to 0.32), while no association was observed with survival with major morbidity (aOR 0.74; 95% CI 0.46 to 1.19) and with NDI (aOR 0.97; 95% CI 0.46 to 2.02). Median age at death (8 vs 4 days) and length of stay (100 vs 73 days) were higher in high than in low activity centres. The results for cohort B mirrored those for cohort A. Centres with high perinatal activity in Switzerland have a significantly lower risk for mortality while having comparable outcomes among survivors. This confirms the results of other studies but in a geographically defined area applying a more restrictive approach to initiation of perinatal intensive care than previous studies. The study adds that infants up to 28 weeks benefited from a higher perinatal activity and why further research is required to better estimate the added burden on children who ultimately do not survive.

Identifiants

pubmed: 30878980
pii: bmjopen-2018-024560
doi: 10.1136/bmjopen-2018-024560
pmc: PMC6429852
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e024560

Investigateurs

Meyer C Anderegg (MC)
A Capone Mori (AC)
D Kaeppeli (D)
S Schulzke (S)
P Weber (P)
G P Ramelli (GP)
B Goeggel Simonetti (BG)
M Nelle (M)
B Wagner (B)
M Steinlin (M)
S Grunt (S)
M Gebauer (M)
R Hassink (R)
W Bär (W)
E Keller (E)
Ch Killer (C)
K Fuhrer (K)
R E Pfister (RE)
P S Hüppi (PS)
C Borradori-Tolsa (C)
J-F Tolsa (JF)
M Roth-Kleiner (M)
M Bickle-Graz (M)
T M Berger (TM)
T Schmitt-Mechelke (T)
F Bauder (F)
V Pezzoli (V)
B Erkert (B)
A Mueller (A)
M Ecoffey (M)
A Malzacher (A)
J P Micallef (JP)
A Lang-Dullenkopf (A)
L Hegi (L)
M Von Rhein (MV)
D Bassler (D)
R Arlettaz (R)
V Bernet (V)
B Latal (B)
G Natalucci (G)
M Moenkhoff (M)

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MA receives a salary as network coordinator for the Swiss Neonatal Network.

Références

Pediatrics. 2013 Jul;132(1):e175-84
pubmed: 23753096
Pediatrics. 2012 Jun;129(6):e1508-16
pubmed: 22641761
Infant Behav Dev. 2015 Nov;41:17-25
pubmed: 26276119
N Engl J Med. 2015 May 7;372(19):1801-11
pubmed: 25946279
J Pediatr. 2012 Aug;161(2):222-8.e3
pubmed: 22421261
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
BMC Pediatr. 2012 Dec 28;12:198
pubmed: 23272671
Arch Dis Child Fetal Neonatal Ed. 2014 May;99(3):F245-9
pubmed: 24554563
BMJ Open. 2017 Jun 15;7(6):e015179
pubmed: 28619775
Arch Dis Child Fetal Neonatal Ed. 2015 Jan;100(1):F82-4
pubmed: 25304321
Arch Dis Child Fetal Neonatal Ed. 2014 May;99(3):F181-8
pubmed: 24604108
Pediatr Res. 2014 May;75(5):670-4
pubmed: 24492622
N Engl J Med. 2015 May 7;372(19):1856-7
pubmed: 25946286
BMC Pediatr. 2017 Apr 17;17(1):106
pubmed: 28415984
Acta Paediatr. 2015 Sep;104(9):872-9
pubmed: 26014127
Acta Paediatr. 2012 Mar;101(3):264-70
pubmed: 22026562
Arch Dis Child Fetal Neonatal Ed. 2009 Nov;94(6):F407-13
pubmed: 19357122
BMJ. 2012 Dec 04;345:e7976
pubmed: 23212881
Clin Perinatol. 2003 Jun;30(2):363-87
pubmed: 12875360
Pediatrics. 2004 Jul;114(1):58-64
pubmed: 15231908
J Dev Behav Pediatr. 2017 Jun;38(5):322-329
pubmed: 28538042
Pediatrics. 2015 May;135(5):e1258-65
pubmed: 25896835
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Cad Saude Publica. 2003 Jan-Feb;19(1):287-95
pubmed: 12700809
Pediatrics. 2015 May;135(5):e1163-72
pubmed: 25896833
Arch Dis Child Fetal Neonatal Ed. 2012 Sep;97(5):F323-8
pubmed: 22933089
BJOG. 2009 Oct;116(11):1481-91
pubmed: 19583715
Swiss Med Wkly. 2011 Oct 18;141:w13280
pubmed: 22009720

Auteurs

Mark Adams (M)

Department of Neonatology, Universitätsspital Zürich, Zürich, Switzerland.
Epidemiology, Biostatistics and Prevention Institute, University Zürich, Zürich, Schweiz, Switzerland.

Thomas M Berger (TM)

Neonatal and Paediatric Intensive Care Unit, Kinderspital Luzern, Luzern, Switzerland.

Cristina Borradori-Tolsa (C)

Department of Paediatrics, Geneva University Hospital, Geneva, Switzerland.

Myriam Bickle-Graz (M)

Department Woman-Mother-Child, University Hospital Lausanne, Lausanne, Switzerland.

Sebastian Grunt (S)

Division of Neuropaediatrics, Development and Rehabilitation, Children's University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Roland Gerull (R)

Department of Neonatology, University of Basel Children's Hospital (UKBB), Basel, Switzerland.

Dirk Bassler (D)

Department of Neonatology, Universitätsspital Zürich, Zürich, Switzerland.

Giancarlo Natalucci (G)

Department of Neonatology, Universitätsspital Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH